What Is Buffett Buying and Selling Now?
In Q4 of last year, Warren Buffett made a few…
Sell
32
ARDX Quote, Financials, Valuation and Earnings
Last price:
$5.46
Seasonality move
:
-17.05%
Day range:
$5.37 - $5.58
52-week range:
$4.32 - $9.33
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.82x
P/B ratio:
7.46x
Volume:
2.2M
Avg. volume:
3.5M
1-year change:
-37.27%
Market cap:
$1.3B
Revenue:
$333.6M
EPS (TTM):
-$0.16
Analysts' Opinion
-
Consensus RatingArdelyx has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $10.75, Ardelyx has an estimated upside of 98.34% from its current price of $5.42.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $5.50 representing -1.48% downside risk from its current price of $5.42.
Fair Value
-
According to the consensus of 11 analysts, Ardelyx has 98.34% upside to fair value with a price target of $10.75 per share.
ARDX vs. S&P 500
-
Over the past 5 trading days, Ardelyx has overperformed the S&P 500 by 6.47% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Ardelyx does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ardelyx has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Ardelyx reported revenues of $116.1M.
Earnings Growth
-
Ardelyx has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Ardelyx reported earnings per share of $0.02.
Enterprise value:
1.2B
EV / Invested capital:
3.68x
Price / LTM sales:
3.82x
EV / EBIT:
--
EV / Revenue:
3.57x
PEG ratio (5yr expected):
-0.11x
EV / Free cash flow:
-26.03x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$283.1M
Return On Assets:
-10.95%
Net Income Margin (TTM):
-11.73%
Return On Equity:
-24.57%
Return On Invested Capital:
-15.08%
Operating Margin:
7%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $52.2M | $124.5M | $333.6M | $34.4M | $116.1M | |
| Gross Profit | $48M | $106.7M | $283.1M | $29.3M | $97.9M | |
| Operating Income | -$63.8M | -$63.3M | -$28M | -$28M | $8.1M | |
| EBITDA | -$61M | -$55.4M | -$16.7M | -$25.3M | $11M | |
| Diluted EPS | -$0.48 | -$0.31 | -$0.16 | -$0.13 | $0.02 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $194.7M | $133.6M | $153.6M | $246.1M | $356.5M | |
| Total Assets | $201.6M | $149.9M | $190.1M | $297.6M | $435.8M | |
| Current Liabilities | $28.4M | $52.8M | $65.6M | $50.4M | $77.8M | |
| Total Liabilities | $75.5M | $67.3M | $91.7M | $130.8M | $262.5M | |
| Total Equity | $126.1M | $82.6M | $98.3M | $166.8M | $173.3M | |
| Total Debt | $50.8M | $32.3M | $26.7M | $49.8M | $150.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$70M | -$89.7M | -$44.8M | -$8.7M | $9.8M | |
| Cash From Investing | $18.4M | -$131.2M | -$18.3M | -$29.6M | -$41.6M | |
| Cash From Financing | $75.3M | $146.3M | $106.6M | $26M | $49.3M | |
| Free Cash Flow | -$70M | -$90.1M | -$45.8M | -$8.8M | $9.2M | |
ARDX
Sector
Market Cap
$1.3B
$38.4M
Price % of 52-Week High
58.09%
45.53%
Dividend Yield
0%
0%
Shareholder Yield
-2.05%
-0.78%
1-Year Price Total Return
-37.27%
-39.05%
Beta (5-Year)
0.873
0.774
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$5.38
200-day SMA
Sell
Level
$5.77
Bollinger Bands (100)
Buy
Level
4.98 - 5.82
Chaikin Money Flow
Sell
Level
-389.4M
20-day SMA
Sell
Level
$5.49
Relative Strength Index (RSI14)
Buy
Level
50.25
ADX Line
Buy
Level
14.3
Williams %R
Neutral
Level
-34.6369
50-day SMA
Buy
Level
$5.39
MACD (12, 26)
Sell
Level
-0.01
25-day Aroon Oscillator
Sell
Level
-12
On Balance Volume
Neutral
Level
506M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.3049)
Sell
CA Score
(Annual)
Level (-0.505)
Sell
Beneish M-Score
(Annual)
Level (-1.0708)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1.591)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
Stock Forecast FAQ
In the current month, ARDX has received 9 Buy ratings 2 Hold ratings, and 0 Sell ratings. The ARDX average analyst price target in the past 3 months is $10.75.
-
Where Will Ardelyx Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ardelyx share price will rise to $10.75 per share over the next 12 months.
-
What Do Analysts Say About Ardelyx?
Analysts are divided on their view about Ardelyx share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ardelyx is a Sell and believe this share price will drop from its current level to $5.50.
-
What Is Ardelyx's Price Target?
The price target for Ardelyx over the next 1-year time period is forecast to be $10.75 according to 11 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is ARDX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ardelyx is a Buy. 9 of 11 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ARDX?
You can purchase shares of Ardelyx via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ardelyx shares.
-
What Is The Ardelyx Share Price Today?
Ardelyx was last trading at $5.46 per share. This represents the most recent stock quote for Ardelyx. Yesterday, Ardelyx closed at $5.42 per share.
-
How To Buy Ardelyx Stock Online?
In order to purchase Ardelyx stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
3 Safest Stocks to Buy Now
With the S&P 500 now in correction and stocks selling…
Tesla Stock: The Bear Case
The recent stock market drop has been a punishing time…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Alerts
Sell
5
CABO alert for Mar 14
Cable One [CABO] is down 3.97% over the past day.
Sell
38
ADBE alert for Mar 14
Adobe [ADBE] is up 4.43% over the past day.
Sell
29
CAR alert for Mar 14
Avis Budget Group [CAR] is up 11.68% over the past day.
